{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:29:35Z","timestamp":1792783775167,"version":"4.5.0"},"reference-count":227,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T00:00:00Z","timestamp":1588636800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81602394"],"award-info":[{"award-number":["81602394"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872210"],"award-info":[{"award-number":["81872210"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2016M591412"],"award-info":[{"award-number":["2016M591412"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2017M610174"],"award-info":[{"award-number":["2017M610174"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Excellent talent science and technology innovation project of Shanxi Province","award":["201605D211029"],"award-info":[{"award-number":["201605D211029"]}]},{"name":"The Excellent talent science and technology innovation project of Shanxi Province","award":["201705D211018"],"award-info":[{"award-number":["201705D211018"]}]},{"name":"The Excellent talent science and technology innovation project of Shanxi Province","award":["201805D211007"],"award-info":[{"award-number":["201805D211007"]}]},{"name":"Shanxi Province Scientific and Technological Achievements Transformation Guidance Foundation","award":["201804D131043"],"award-info":[{"award-number":["201804D131043"]}]},{"name":"Youth Top Talent Program Fund of Shanxi Province","award":["2018"],"award-info":[{"award-number":["2018"]}]},{"name":"Fund of Shanxi \u201c1331\u201d Project","award":["2018"],"award-info":[{"award-number":["2018"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.biopha.2020.110231","type":"journal-article","created":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T17:05:05Z","timestamp":1589648705000},"page":"110231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Non-coding RNAs in drug resistance of head and neck cancers: A review"],"prefix":"10.1016","volume":"127","author":[{"given":"Fengsheng","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiwang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujia","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuliang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huizheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuxin","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanglai","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changming","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongyan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7836-2851","authenticated-orcid":false,"given":"Wei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.biopha.2020.110231_bib0005","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.biopha.2020.110231_bib0010","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1056\/NEJMra1715715","article-title":"Head and neck cancer","volume":"382","author":"Chow","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.biopha.2020.110231_bib0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrc2982","article-title":"The molecular biology of head and neck cancer","volume":"11","author":"Leemans","year":"2011","journal-title":"Nat. Rev. Cancer"},{"issue":"16","key":"10.1016\/j.biopha.2020.110231_bib0020","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1517\/14656566.2015.1085507","article-title":"Pharmacotherapy of head and neck cancer","volume":"16","author":"Nwizu","year":"2015","journal-title":"Expert Opin. Pharmacother."},{"issue":"7","key":"10.1016\/j.biopha.2020.110231_bib0025","doi-asserted-by":"crossref","first-page":"666","DOI":"10.2174\/156800907782418293","article-title":"Treatment of squamous cell carcinoma of the head and neck in the metastatic and refractory settings: advances in chemotherapy and the emergence of small molecule epidermal growth factor receptor kinase inhibitors","volume":"7","author":"Ahmed","year":"2007","journal-title":"Curr. Cancer Drug Targets"},{"issue":"7","key":"10.1016\/j.biopha.2020.110231_bib0030","doi-asserted-by":"crossref","first-page":"e343","DOI":"10.1016\/S1470-2045(18)30452-2","article-title":"Concurrent chemotherapy improves outcomes in HNSCC","volume":"19","author":"Gourd","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.biopha.2020.110231_bib0035","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.oraloncology.2015.10.020","article-title":"Individualised quality of life as a measure to guide treatment choices in squamous cell carcinoma of the head and neck","volume":"52","author":"Licitra","year":"2016","journal-title":"Oral Oncol."},{"issue":"11","key":"10.1016\/j.biopha.2020.110231_bib0040","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41571-019-0227-z","article-title":"The changing therapeutic landscape of head and neck cancer","volume":"16","author":"Cramer","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biopha.2020.110231_bib0045","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ctrv.2016.01.002","article-title":"Chemotherapy in locally advanced head and neck squamous cell carcinoma","volume":"44","author":"Gyawali","year":"2016","journal-title":"Cancer Treat. Rev."},{"issue":"9\u201310","key":"10.1016\/j.biopha.2020.110231_bib0050","first-page":"1533","article-title":"Cis-dichlorodiammineplatinum(II)-based chemotherapy as initial treatment of advanced head and neck cancer","volume":"63","author":"Wittes","year":"1979","journal-title":"Cancer Treat. Rep."},{"issue":"12","key":"10.1016\/j.biopha.2020.110231_bib0055","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1002\/hed.21977","article-title":"Second, third, and fourth head and neck tumors. A progressive decrease in survival","volume":"34","author":"Le\u00f3n","year":"2012","journal-title":"Head Neck"},{"issue":"11","key":"10.1016\/j.biopha.2020.110231_bib0060","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1177\/0022034515601960","article-title":"Targeting head and neck cancer stem cells: current advances and future challenges","volume":"94","author":"Birkeland","year":"2015","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.biopha.2020.110231_bib0065","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.oraloncology.2017.04.002","article-title":"Outcome of recurrent and metastatic head and neck squamous cell cancer patients after first line platinum and cetuximab therapy","volume":"69","author":"Siano","year":"2017","journal-title":"Oral Oncol."},{"issue":"10","key":"10.1016\/j.biopha.2020.110231_bib0070","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc3599","article-title":"Cancer drug resistance: an evolving paradigm","volume":"13","author":"Holohan","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.biopha.2020.110231_bib0075","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.canlet.2014.08.026","article-title":"Modulating cancer multidrug resistance by sertraline in combination with a nanomedicine","volume":"354","author":"Drinberg","year":"2014","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.biopha.2020.110231_bib0080","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s12272-013-0276-2","article-title":"Cancer multidrug resistance: mechanisms involved and strategies for circumvention using a drug delivery system","volume":"37","author":"Kibria","year":"2014","journal-title":"Arch. Pharm. Res."},{"issue":"1","key":"10.1016\/j.biopha.2020.110231_bib0085","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.18632\/oncotarget.12461","article-title":"Long non-coding RNAs in anti-cancer drug resistance","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.biopha.2020.110231_bib0090","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/carcin\/bgx026","article-title":"Small non-coding RNA and cancer","volume":"38","author":"Romano","year":"2017","journal-title":"Carcinogenesis"},{"issue":"4","key":"10.1016\/j.biopha.2020.110231_bib0095","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1152\/physrev.00041.2015","article-title":"Non-coding RNAs in development and disease: background, mechanisms, and therapeutic approaches","volume":"96","author":"Beermann","year":"2016","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.biopha.2020.110231_bib0100","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.yjmcc.2015.11.012","article-title":"Non-coding RNAs as orchestrators of autophagic processes","volume":"95","author":"Gupta","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"6099","key":"10.1016\/j.biopha.2020.110231_bib0105","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1126\/science.1222794","article-title":"Systematic localization of common disease-associated variation in regulatory DNA","volume":"337","author":"Maurano","year":"2012","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.biopha.2020.110231_bib0110","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12943-019-1002-6","article-title":"Circular RNAs in Cancer: emerging functions in hallmarks, stemness, resistance and roles as potential biomarkers","volume":"18","author":"Su","year":"2019","journal-title":"Mol. Cancer"},{"issue":"11","key":"10.1016\/j.biopha.2020.110231_bib0115","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/nm.4424","article-title":"lncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt\/\u03b2-catenin signaling","volume":"23","author":"Lu","year":"2017","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.biopha.2020.110231_bib0120","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13148-018-0587-8","article-title":"The role and mechanisms of action of microRNAs in cancer drug resistance","volume":"11","author":"Si","year":"2019","journal-title":"Clin. Epigenetics"},{"issue":"3","key":"10.1016\/j.biopha.2020.110231_bib0125","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3390\/genes8030095","article-title":"Influence of microRNAs and long non-coding RNAs in cancer chemoresistance","volume":"8","author":"Ayers","year":"2017","journal-title":"Genes (Basel)"},{"issue":"3","key":"10.1016\/j.biopha.2020.110231_bib0130","doi-asserted-by":"crossref","first-page":"321","DOI":"10.7150\/ijbs.24360","article-title":"Overexpressed circPVT1, a potential new circular RNA biomarker, contributes to doxorubicin and cisplatin resistance of osteosarcoma cells by regulating ABCB1","volume":"14","author":"Kun-Peng","year":"2018","journal-title":"Int. J. Biol. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2020.110231_bib0135","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","article-title":"The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14","volume":"75","author":"Lee","year":"1993","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.biopha.2020.110231_bib0140","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.biopha.2020.110231_bib0145","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1002\/cmdc.201300534","article-title":"Long noncoding RNAs: emerging stars in gene regulation, epigenetics and human disease","volume":"9","author":"Bhan","year":"2014","journal-title":"ChemMedChem"},{"issue":"5","key":"10.1016\/j.biopha.2020.110231_bib0150","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.molcel.2015.03.027","article-title":"Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed","volume":"58","author":"Rybak-Wolf","year":"2015","journal-title":"Mol. Cell"},{"issue":"6","key":"10.1016\/j.biopha.2020.110231_bib0155","first-page":"1167","article-title":"Circular RNAs as potential biomarkers for cancer diagnosis and therapy","volume":"6","author":"Wang","year":"2016","journal-title":"Am. J. Cancer Res."},{"issue":"12","key":"10.1016\/j.biopha.2020.110231_bib0160","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1261\/rna.047126.114","article-title":"Circular RNAs: diversity of form and function","volume":"20","author":"Lasda","year":"2014","journal-title":"RNA"},{"issue":"2","key":"10.1016\/j.biopha.2020.110231_bib0165","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1261\/rna.035667.112","article-title":"Circular RNAs are abundant, conserved, and associated with ALU repeats","volume":"19","author":"Jeck","year":"2013","journal-title":"RNA"},{"issue":"4","key":"10.1016\/j.biopha.2020.110231_bib0170","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.cell.2016.07.035","article-title":"Oncogenic role of Fusion-circRNAs derived from cancer-associated chromosomal translocations","volume":"166","author":"Guarnerio","year":"2016","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.biopha.2020.110231_bib0175","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.3892\/etm.2011.331","article-title":"Expression and function of ABCG2 in head and neck squamous cell carcinoma and cell lines","volume":"2","author":"Shen","year":"2011","journal-title":"Exp. Ther. Med."},{"issue":"1","key":"10.1016\/j.biopha.2020.110231_bib0180","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3892\/mmr.2014.2212","article-title":"Role and mechanism of Twist1 in modulating the chemosensitivity of FaDu cells","volume":"10","author":"Lu","year":"2014","journal-title":"Mol. Med. Rep."},{"issue":"15","key":"10.1016\/j.biopha.2020.110231_bib0185","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/onc.2011.384","article-title":"Molecular mechanisms of cisplatin resistance","volume":"31","author":"Galluzzi","year":"2012","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.biopha.2020.110231_bib0190","doi-asserted-by":"crossref","first-page":"660","DOI":"10.2174\/156800910793605866","article-title":"Oxaliplatin-mediated inhibition of survivin increases sensitivity of head and neck squamous cell carcinoma cell lines to paclitaxel","volume":"10","author":"Khan","year":"2010","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.biopha.2020.110231_bib0195","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"18","key":"10.1016\/j.biopha.2020.110231_bib0200","doi-asserted-by":"crossref","first-page":"4561","DOI":"10.1158\/1078-0432.CCR-10-0593","article-title":"Regulation of excision repair cross-complementation group 1 by Snail contributes to cisplatin resistance in head and neck cancer","volume":"16","author":"Hsu","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"16","key":"10.1016\/j.biopha.2020.110231_bib0205","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1200\/JCO.2006.06.6605","article-title":"Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer","volume":"25","author":"Temam","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110231_bib0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2016.04.023","article-title":"Elevated RET expression enhances EGFR activation and mediates EGFR inhibitor resistance in head and neck squamous cell carcinoma","volume":"377","author":"Lin","year":"2016","journal-title":"Cancer Lett."},{"issue":"4\u20135","key":"10.1016\/j.biopha.2020.110231_bib0215","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.drup.2010.07.001","article-title":"Targeting miRNAs involved in cancer stem cell and EMT regulation: an emerging concept in overcoming drug resistance","volume":"13","author":"Wang","year":"2010","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.biopha.2020.110231_bib0220","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/1476-4598-13-121","article-title":"miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer","volume":"13","author":"Yu","year":"2014","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.biopha.2020.110231_bib0225","doi-asserted-by":"crossref","first-page":"497","DOI":"10.7150\/jca.17444","article-title":"Identification and characterization of CD133+CD44+ cancer stem cells from human laryngeal squamous cell carcinoma cell lines","volume":"8","author":"Wang","year":"2017","journal-title":"J. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2020.110231_bib0230","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","article-title":"Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets","volume":"120","author":"Lewis","year":"2005","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.biopha.2020.110231_bib0235","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1002\/jcp.26810","article-title":"MicroRNAs in cancer drug resistance: basic evidence and clinical applications","volume":"234","author":"Ghasabi","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"13","key":"10.1016\/j.biopha.2020.110231_bib0240","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1016\/j.yexcr.2013.05.014","article-title":"Small interfering RNA targeting ILK inhibits metastasis in human tongue cancer cells through repression of epithelial-to-mesenchymal transition","volume":"319","author":"Xing","year":"2013","journal-title":"Exp. Cell Res."},{"issue":"6","key":"10.1016\/j.biopha.2020.110231_bib0245","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.febslet.2010.12.045","article-title":"Cloning and functional characterization of TCRP1, a novel gene mediating resistance to cisplatin in an oral squamous cell carcinoma cell line","volume":"585","author":"Gu","year":"2011","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.biopha.2020.110231_bib0250","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrc2982","article-title":"The molecular biology of head and neck cancer","volume":"11","author":"Leemans","year":"2011","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.biopha.2020.110231_bib0255","first-page":"1003","article-title":"Let-7d functions as novel regulator of epithelial-mesenchymal transition and chemoresistant property in oral cancer","volume":"26","author":"Chang","year":"2011","journal-title":"Oncol. Rep."},{"issue":"8","key":"10.1016\/j.biopha.2020.110231_bib0260","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1002\/ijc.26190","article-title":"Let-7 modulates acquired resistance of ovarian cancer to Taxanes via IMP-1-mediated stabilization of multidrug resistance 1","volume":"130","author":"Boyerinas","year":"2012","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.biopha.2020.110231_bib0265","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1159\/000491523","article-title":"Let-7d inhibits growth and metastasis in breast cancer by targeting Jab1\/Cops5","volume":"47","author":"Wei","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.biopha.2020.110231_bib0270","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.2147\/OTT.S141008","article-title":"let-7d suppresses proliferation and invasion and promotes apoptosis of meningioma by targeting AEG-1","volume":"10","author":"Li","year":"2017","journal-title":"Onco Ther."},{"issue":"1","key":"10.1016\/j.biopha.2020.110231_bib0275","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s11033-018-4462-7","article-title":"Preliminary study on the effect of nucleolin specific aptamer-miRNA let-7d chimera on Janus kinase-2 expression level and activity in gastric cancer (MKN-45) cells","volume":"46","author":"Ramezanpour","year":"2019","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.biopha.2020.110231_bib0280","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/1476-4598-13-206","article-title":"Let-7d suppresses growth, metastasis, and tumor macrophage infiltration in renal cell carcinoma by targeting COL3A1 and CCL7","volume":"13","author":"Su","year":"2014","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2020.110231_bib0285","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.pan.2018.10.012","article-title":"MicroRNA let-7d targets thrombospondin-1 and inhibits the activation of human pancreatic stellate cells","volume":"19","author":"Asama","year":"2019","journal-title":"Pancreatology"},{"issue":"1","key":"10.1016\/j.biopha.2020.110231_bib0290","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13046-019-1091-5","article-title":"A novel miR-365-3p\/EHF\/keratin 16 axis promotes oral squamous cell carcinoma metastasis, cancer stemness and drug resistance via enhancing \u03b25-integrin\/c-met signaling pathway","volume":"38","author":"Huang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.biopha.2020.110231_bib0295","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1089\/dna.2017.4095","article-title":"miR-654-5p targets GRAP to promote proliferation, metastasis, and chemoresistance of oral squamous cell carcinoma through Ras\/MAPK signaling","volume":"37","author":"Lu","year":"2018","journal-title":"DNA Cell Biol."},{"issue":"2","key":"10.1016\/j.biopha.2020.110231_bib0300","first-page":"522","article-title":"MiR-654-5p attenuates breast cancer progression by targeting EPSTI1","volume":"6","author":"Tan","year":"2016","journal-title":"Am. J. Cancer Res."},{"issue":"4","key":"10.1016\/j.biopha.2020.110231_bib0305","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s12032-016-0749-5","article-title":"Micro-RNA (miRNA) profile in Hodgkin lymphoma: association between clinical and pathological variables","volume":"33","author":"Paydas","year":"2016","journal-title":"Med. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110231_bib0310","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s13046-019-1114-2","article-title":"A positive feedback loop consisting of C12orf59\/NF-\u03baB\/CDH11 promotes gastric cancer invasion and metastasis","volume":"38","author":"Zhang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.biopha.2020.110231_bib0315","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1158\/0008-5472.CAN-10-2421","article-title":"Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells","volume":"71","author":"\u00d6stling","year":"2011","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.biopha.2020.110231_bib0320","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.oraloncology.2015.08.002","article-title":"MicroRNA-24 induces cisplatin resistance by targeting PTEN in human tongue squamous cell carcinoma","volume":"51","author":"Zheng","year":"2015","journal-title":"Oral Oncol."},{"issue":"12","key":"10.1016\/j.biopha.2020.110231_bib0325","doi-asserted-by":"crossref","first-page":"19507","DOI":"10.18632\/oncotarget.14470","article-title":"MiR-24 induces chemotherapy resistance and hypoxic advantage in breast cancer","volume":"8","author":"Roscigno","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.biopha.2020.110231_bib0330","doi-asserted-by":"crossref","first-page":"942","DOI":"10.3892\/or.2014.3664","article-title":"miR-23a promotes cisplatin chemoresistance and protects against cisplatin-induced apoptosis in tongue squamous cell carcinoma cells through Twist","volume":"33","author":"Peng","year":"2015","journal-title":"Oncol. Rep."},{"issue":"3","key":"10.1016\/j.biopha.2020.110231_bib0335","first-page":"1382","article-title":"Pristimerin enhances the effect of cisplatin by inhibiting the miR\u201123a\/Akt\/GSK3\u03b2 signaling pathway and suppressing autophagy in lung cancer cells","volume":"43","author":"Zhang","year":"2019","journal-title":"Int. J. Mol. Med."},{"issue":"4","key":"10.1016\/j.biopha.2020.110231_bib0340","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2174\/138920371604150429153309","article-title":"Elevated microRNA-23a expression enhances the chemoresistance of colorectal Cancer cells with microsatellite instability to 5-fluorouracil by directly targeting ABCF1","volume":"16","author":"Li","year":"2015","journal-title":"Curr. Protein Pept. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2020.110231_bib0345","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/1476-4598-12-119","article-title":"MiR-23a-mediated inhibition of topoisomerase 1 expression potentiates cell response to etoposide in human hepatocellular carcinoma","volume":"12","author":"Wang","year":"2013","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.biopha.2020.110231_bib0350","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.bbrc.2013.10.051","article-title":"miR-181a-Twist1 pathway in the chemoresistance of tongue squamous cell carcinoma","volume":"441","author":"Liu","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"9","key":"10.1016\/j.biopha.2020.110231_bib0355","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/pros.23358","article-title":"MicroRNA-181a promotes docetaxel resistance in prostate cancer cells","volume":"77","author":"Armstrong","year":"2017","journal-title":"Prostate"},{"issue":"4","key":"10.1016\/j.biopha.2020.110231_bib0360","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1016\/j.bbrc.2017.12.096","article-title":"MiR-181a contributes gefitinib resistance in non-small cell lung cancer cells by targeting GAS7","volume":"495","author":"Ping","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.biopha.2020.110231_bib0365","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1080\/15384047.2016.1139244","article-title":"Role of miR-27a, miR-181a and miR-20b in gastric cancer hypoxia-induced chemoresistance","volume":"17","author":"Danza","year":"2016","journal-title":"Cancer Biol. Ther."},{"issue":"3","key":"10.1016\/j.biopha.2020.110231_bib0370","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s10549-013-2607-x","article-title":"MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP\/ABCG2)","volume":"139","author":"Jiao","year":"2013","journal-title":"Breast Cancer Res. Treat."},{"issue":"7","key":"10.1016\/j.biopha.2020.110231_bib0375","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1002\/jcb.25910","article-title":"LncRNA CASC2 interacts with miR-181a to modulate glioma growth and resistance to TMZ through PTEN pathway","volume":"118","author":"Liao","year":"2017","journal-title":"J. Cell. Biochem."},{"issue":"4","key":"10.1016\/j.biopha.2020.110231_bib0380","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/onc.2011.263","article-title":"MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1","volume":"31","author":"Sun","year":"2012","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.biopha.2020.110231_bib0385","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.3892\/or.2017.5532","article-title":"miR-15b inhibits cancer-initiating cell phenotypes and chemoresistance of cisplatin by targeting TRIM14 in oral tongue squamous cell cancer","volume":"37","author":"Wang","year":"2017","journal-title":"Oncol. Rep."},{"issue":"131","key":"10.1016\/j.biopha.2020.110231_bib0390","first-page":"75","article-title":"miR-200b regulates epithelial-mesenchymal transition of chemo-resistant breast cancer cells by targeting FN1","volume":"24","author":"Yang","year":"2017","journal-title":"Discov. Med."},{"issue":"2","key":"10.1016\/j.biopha.2020.110231_bib0395","first-page":"1453","article-title":"miR-200b and miR-200c co-contribute to the cisplatin sensitivity of ovarian cancer cells by targeting DNA methyltransferases","volume":"17","author":"Liu","year":"2019","journal-title":"Oncol. Lett."},{"issue":"2","key":"10.1016\/j.biopha.2020.110231_bib0400","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3892\/or.2013.2897","article-title":"miR-200b suppresses cell proliferation, migration and enhances chemosensitivity in prostate cancer by regulating Bmi-1","volume":"31","author":"Yu","year":"2014","journal-title":"Oncol. Rep."},{"issue":"3","key":"10.1016\/j.biopha.2020.110231_bib0405","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.yexmp.2014.04.008","article-title":"Zinc finger E-box-binding homeobox 2 (ZEB2) regulated by miR-200b contributes to multi-drug resistance of small cell lung cancer","volume":"96","author":"Fang","year":"2014","journal-title":"Exp. Mol. Pathol."},{"issue":"3","key":"10.1016\/j.biopha.2020.110231_bib0410","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.3892\/ijo.2015.3076","article-title":"miR-15b promotes epithelial-mesenchymal transition by inhibiting SMURF2 in pancreatic cancer","volume":"47","author":"Zhang","year":"2015","journal-title":"Int. J. Oncol."},{"issue":"3","key":"10.1016\/j.biopha.2020.110231_bib0415","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/cgt.2014.73","article-title":"miR-15b regulates cisplatin resistance and metastasis by targeting PEBP4 in human lung adenocarcinoma cells","volume":"22","author":"Zhao","year":"2015","journal-title":"Cancer Gene Ther."},{"issue":"1","key":"10.1016\/j.biopha.2020.110231_bib0420","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1038\/s41598-017-04172-z","article-title":"miR-15b-5p resensitizes colon cancer cells to 5-fluorouracil by promoting apoptosis via the NF-\u03baB\/XIAP axis","volume":"7","author":"Zhao","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.biopha.2020.110231_bib0425","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/ijc.23501","article-title":"miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells","volume":"123","author":"Xia","year":"2008","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.biopha.2020.110231_bib0430","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/1878-0261.12015","article-title":"miR-15b modulates multidrug resistance in human osteosarcoma in vitro and in vivo","volume":"11","author":"Duan","year":"2017","journal-title":"Mol. Oncol."},{"issue":"42","key":"10.1016\/j.biopha.2020.110231_bib0435","doi-asserted-by":"crossref","first-page":"44538","DOI":"10.18632\/oncotarget.6253","article-title":"Deregulation of the miR-222-ABCG2 regulatory module in tongue squamous cell carcinoma contributes to chemoresistance and enhanced migratory\/invasive potential","volume":"6","author":"Zhao","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2020.110231_bib0440","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.gene.2016.10.016","article-title":"MiR-222 promotes drug-resistance of breast cancer cells to adriamycin via modulation of PTEN\/Akt\/FOXO1 pathway","volume":"596","author":"Shen","year":"2017","journal-title":"Gene"},{"issue":"3","key":"10.1016\/j.biopha.2020.110231_bib0445","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/jcmm.12760","article-title":"miR-222 attenuates cisplatin-induced cell death by targeting the PPP2R2A\/Akt\/mTOR Axis in bladder cancer cells","volume":"20","author":"Zeng","year":"2016","journal-title":"J. Cell. Mol. Med."},{"issue":"17","key":"10.1016\/j.biopha.2020.110231_bib0450","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/j.yexcr.2012.04.014","article-title":"MiR-222 modulates multidrug resistance in human colorectal carcinoma by down-regulating ADAM-17","volume":"318","author":"Xu","year":"2012","journal-title":"Exp. Cell Res."},{"issue":"1-2","key":"10.1016\/j.biopha.2020.110231_bib0455","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s11010-014-1976-8","article-title":"MiR-21 modulates chemosensitivity of tongue squamous cell carcinoma cells to cisplatin by targeting PDCD4","volume":"390","author":"Ren","year":"2014","journal-title":"Mol. Cell. Biochem."},{"issue":"10","key":"10.1016\/j.biopha.2020.110231_bib0460","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s00109-016-1417-0","article-title":"MYCN-mediated miR-21 overexpression enhances chemo-resistance via targeting CADM1 in tongue cancer","volume":"94","author":"Zheng","year":"2016","journal-title":"J. Mol. Med."},{"issue":"9","key":"10.1016\/j.biopha.2020.110231_bib0465","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/abbs\/gmx078","article-title":"Exosomes containing miR-21 transfer the characteristic of cisplatin resistance by targeting PTEN and PDCD4 in oral squamous cell carcinoma","volume":"49","author":"Liu","year":"2017","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"issue":"6","key":"10.1016\/j.biopha.2020.110231_bib0470","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3727\/096504017X14934840662335","article-title":"Micro-RNA-21 regulates cancer-associated fibroblast-mediated drug resistance in pancreatic cancer","volume":"26","author":"Zhang","year":"2018","journal-title":"Oncol. Res."},{"issue":"1","key":"10.1016\/j.biopha.2020.110231_bib0475","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13046-017-0528-y","article-title":"Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells","volume":"36","author":"Zheng","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"30","key":"10.1016\/j.biopha.2020.110231_bib0480","doi-asserted-by":"crossref","first-page":"28867","DOI":"10.18632\/oncotarget.4814","article-title":"MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN\/Akt pathway","volume":"6","author":"He","year":"2015","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.biopha.2020.110231_bib0485","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/cam4.626","article-title":"MicroRNA-21 induces 5-fluorouracil resistance in human pancreatic cancer cells by regulating PTEN and PDCD4","volume":"5","author":"Wei","year":"2016","journal-title":"Cancer Med."},{"issue":"7","key":"10.1016\/j.biopha.2020.110231_bib0490","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317707372","article-title":"Targeting miR-21 decreases expression of multi-drug resistant genes and promotes chemosensitivity of renal carcinoma","volume":"39","author":"Gaudelot","year":"2017","journal-title":"Tumour Biol."},{"key":"10.1016\/j.biopha.2020.110231_bib0495","doi-asserted-by":"crossref","first-page":"18706","DOI":"10.1038\/srep18706","article-title":"Morphine, a potential antagonist of cisplatin cytotoxicity, inhibits cisplatin-induced apoptosis and suppression of tumor growth in nasopharyngeal carcinoma xenografts","volume":"6","author":"Cao","year":"2016","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.biopha.2020.110231_bib0500","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0360-3016(00)00779-3","article-title":"Long-term survival of nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy","volume":"48","author":"Cheng","year":"2000","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"10","key":"10.1016\/j.biopha.2020.110231_bib0505","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078355","article-title":"Epstein-Barr Virus_Encoded LMP1 upregulates microRNA-21 to promote the resistance of nasopharyngeal carcinoma cells to cisplatin-induced Apoptosis by suppressing PDCD4 and Fas-L","volume":"8","author":"Yang","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.biopha.2020.110231_bib0510","first-page":"6784","article-title":"MiR-634 sensitizes nasopharyngeal carcinoma cells to paclitaxel and inhibits cell growth both in vitro and in vivo","volume":"7","author":"Peng","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.biopha.2020.110231_bib0515","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s12943-015-0464-4","article-title":"miR-634 restores drug sensitivity in resistant ovarian cancer cells by targeting the Ras-MAPK pathway","volume":"14","author":"van Jaarsveld","year":"2015","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.biopha.2020.110231_bib0520","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/cam4.1351","article-title":"MiR-634 sensitizes glioma cells to temozolomide by targeting CYR61 through Raf-ERK signaling pathway","volume":"7","author":"Tan","year":"2018","journal-title":"Cancer Med."},{"issue":"12","key":"10.1016\/j.biopha.2020.110231_bib0525","first-page":"715","article-title":"MicroRNA-132 sensitizes nasopharyngeal carcinoma cells to cisplatin through regulation of forkhead box A1 protein","volume":"71","author":"Li","year":"2016","journal-title":"Pharmazie"},{"issue":"9","key":"10.1016\/j.biopha.2020.110231_bib0530","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1002\/mc.22656","article-title":"Upregulated miR-132 in Lgr5+ gastric cancer stem cell-like cells contributes to cisplatin-resistance via SIRT1\/CREB\/ABCG2 signaling pathway","volume":"56","author":"Zhang","year":"2017","journal-title":"Mol. Carcinog."},{"issue":"6","key":"10.1016\/j.biopha.2020.110231_bib0535","first-page":"398","article-title":"miR-132 regulates adriamycin resistance in colorectal Cancer cells through targeting extracellular signal-regulated kinase 1","volume":"34","author":"Liu","year":"2019","journal-title":"Cancer Biother. Radiopharm."},{"issue":"5","key":"10.1016\/j.biopha.2020.110231_bib0540","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.3892\/ijmm.2017.3124","article-title":"MicroRNA-132 induces temozolomide resistance and promotes the formation of cancer stem cell phenotypes by targeting tumor suppressor candidate 3 in glioblastoma","volume":"40","author":"Cheng","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.biopha.2020.110231_bib0545","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.biopha.2018.03.088","article-title":"MicroRNA-132 and microRNA-212 mediate doxorubicin resistance by down-regulating the PTEN-AKT\/NF-\u03baB signaling pathway in breast cancer","volume":"102","author":"Xie","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.biopha.2020.110231_bib0550","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.3892\/mmr.2017.6233","article-title":"microRNA-125b reverses the multidrug resistance of nasopharyngeal carcinoma cells via targeting of Bcl-2","volume":"15","author":"Yuan","year":"2017","journal-title":"Mol. Med. Rep."},{"issue":"4","key":"10.1016\/j.biopha.2020.110231_bib0555","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s11596-011-0487-z","article-title":"miR-125b confers resistance of ovarian cancer cells to cisplatin by targeting pro-apoptotic Bcl-2 antagonist killer 1","volume":"31","author":"Kong","year":"2011","journal-title":"J. Huazhong Univ. Sci. Technol. Med. Sci."},{"key":"10.1016\/j.biopha.2020.110231_bib0560","doi-asserted-by":"crossref","first-page":"43109","DOI":"10.1038\/srep43109","article-title":"miR-125b-5p enhances chemotherapy sensitivity to cisplatin by down-regulating Bcl2 in gallbladder cancer","volume":"7","author":"Yang","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.biopha.2020.110231_bib0565","first-page":"1621","article-title":"miR-125b regulates the drug-resistance of breast cancer cells to doxorubicin by targeting HAX-1","volume":"15","author":"Hu","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.biopha.2020.110231_bib0570","doi-asserted-by":"crossref","first-page":"42226","DOI":"10.1038\/srep42226","article-title":"CXCL12\/CXCR4 axis induced miR-125b promotes invasion and confers 5-fluorouracil resistance through enhancing autophagy in colorectal cancer","volume":"7","author":"Yu","year":"2017","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.biopha.2020.110231_bib0575","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/2211-5463.12135","article-title":"Down-regulation of miR-26b induces cisplatin resistance in nasopharyngeal carcinoma by repressing JAG1","volume":"6","author":"Shi","year":"2016","journal-title":"FEBS Open Bio"},{"issue":"20","key":"10.1016\/j.biopha.2020.110231_bib0580","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1080\/15384101.2017.1367071","article-title":"MiR-26b reverses temozolomide resistance via targeting Wee1 in glioma cells","volume":"16","author":"Wang","year":"2017","journal-title":"Cell Cycle"},{"issue":"2","key":"10.1016\/j.biopha.2020.110231_bib0585","doi-asserted-by":"crossref","first-page":"498","DOI":"10.5114\/aoms.2018.73315","article-title":"Mir-26b inhibits growth and resistance to paclitaxel chemotherapy by silencing the CDC6 gene in gastric cancer","volume":"15","author":"Zhao","year":"2019","journal-title":"Arch. Med. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2020.110231_bib0590","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/abbs\/gmv046","article-title":"Down-regulation of microRNA-26b modulates non-small cell lung cancer cells chemoresistance and migration through the association of PTEN","volume":"47","author":"Liang","year":"2015","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"key":"10.1016\/j.biopha.2020.110231_bib0595","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1476-4598-13-35","article-title":"MicroRNA-26b suppresses the NF-\u03baB signaling and enhances the chemosensitivity of hepatocellular carcinoma cells by targeting TAK1 and TAB3","volume":"13","author":"Zhao","year":"2014","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2020.110231_bib0600","first-page":"31","article-title":"An update on larynx cancer","volume":"67","author":"Steuer","year":"2017","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.biopha.2020.110231_bib0605","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s12013-014-0194-z","article-title":"Clinical implications of BMI-1 in cancer stem cells of laryngeal carcinoma","volume":"71","author":"Yu","year":"2015","journal-title":"Cell Biochem. Biophys."},{"issue":"52","key":"10.1016\/j.biopha.2020.110231_bib0610","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.13424","article-title":"Inhibition of HAX-1 by miR-125a reverses cisplatin resistance in laryngeal cancer stem cells","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.biopha.2020.110231_bib0615","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.3892\/ijmm.2016.2569","article-title":"miR-133a enhances the sensitivity of Hep-2 cells and vincristine-resistant Hep-2v cells to cisplatin by downregulating ATP7B expression","volume":"37","author":"Wang","year":"2016","journal-title":"Int. J. Mol. Med."},{"issue":"45","key":"10.1016\/j.biopha.2020.110231_bib0620","doi-asserted-by":"crossref","first-page":"79023","DOI":"10.18632\/oncotarget.20784","article-title":"Overexpression of miR-26b decreases the cisplatin-resistance in laryngeal cancer by targeting ATF2","volume":"8","author":"Tian","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.biopha.2020.110231_bib0625","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/pcmr.12578","article-title":"MicroRNA-125a promotes resistance to BRAF inhibitors through suppression of the intrinsic apoptotic pathway","volume":"30","author":"Koetz-Ploch","year":"2017","journal-title":"Pigment Cell Melanoma Res."},{"issue":"2","key":"10.1016\/j.biopha.2020.110231_bib0630","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/abbs\/gmv129","article-title":"MiR-125a regulates chemo-sensitivity to gemcitabine in human pancreatic cancer cells through targeting A20","volume":"48","author":"Yao","year":"2016","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"issue":"1","key":"10.1016\/j.biopha.2020.110231_bib0635","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/07357907.2012.743557","article-title":"MiR-125a\/b regulates the activation of cancer stem cells in paclitaxel-resistant colon cancer","volume":"31","author":"Chen","year":"2013","journal-title":"Cancer Invest."},{"issue":"4","key":"10.1016\/j.biopha.2020.110231_bib0640","doi-asserted-by":"crossref","first-page":"6235","DOI":"10.3892\/mmr.2015.4134","article-title":"MicroRNA\u2011133a and microRNA\u2011326 co\u2011contribute to hepatocellular carcinoma 5\u2011fluorouracil and cisplatin sensitivity by directly targeting B\u2011cell lymphoma\u2011extra large","volume":"12","author":"Ma","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"6","key":"10.1016\/j.biopha.2020.110231_bib0645","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129843","article-title":"MiR-133a is functionally involved in doxorubicin-resistance in breast cancer cells MCF-7 via its regulation of the expression of uncoupling protein 2","volume":"10","author":"Yuan","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biopha.2020.110231_bib0650","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12022-007-0002-z","article-title":"Changing patterns in the incidence and survival of thyroid cancer with follicular phenotype--papillary, follicular, and anaplastic: a morphological and epidemiological study","volume":"18","author":"Albores-Saavedra","year":"2007","journal-title":"Endocr. Pathol."},{"issue":"4-6","key":"10.1016\/j.biopha.2020.110231_bib0655","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000185458","article-title":"Origin and progression of thyroid epithelial tumours: cellular and molecular mechanisms","volume":"47","author":"Wynford-Thomas","year":"1997","journal-title":"Horm. Res."},{"issue":"21","key":"10.1016\/j.biopha.2020.110231_bib0660","doi-asserted-by":"crossref","first-page":"10148","DOI":"10.1158\/0008-5472.CAN-07-1887","article-title":"A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinoma","volume":"67","author":"Salvatore","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2020.110231_bib0665","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108605","article-title":"Over-expression of miR-206 decreases the Euthyrox-resistance by targeting MAP4K3 in papillary thyroid carcinoma","volume":"114","author":"Liu","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.biopha.2020.110231_bib0670","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/bcpt.13076","article-title":"miR-27b-3p is involved in doxorubicin resistance of human anaplastic thyroid cancer cells via targeting peroxisome proliferator-activated receptor gamma","volume":"123","author":"Xu","year":"2018","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"2","key":"10.1016\/j.biopha.2020.110231_bib0675","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s41419-017-0211-4","article-title":"miR-27b-3p inhibits proliferation and potentially reverses multi-chemoresistance by targeting CBLB\/GRB2 in breast cancer cells","volume":"9","author":"Chen","year":"2018","journal-title":"Cell Death Dis."},{"issue":"11","key":"10.1016\/j.biopha.2020.110231_bib0680","doi-asserted-by":"crossref","first-page":"e2454","DOI":"10.1038\/cddis.2016.361","article-title":"Downregulation of microRNA-27b-3p enhances tamoxifen resistance in breast cancer by increasing NR5A2 and CREB1 expression","volume":"7","author":"Zhu","year":"2016","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.biopha.2020.110231_bib0685","first-page":"171","article-title":"MicroRNA-206 facilitates gastric cancer cell apoptosis and suppresses cisplatin resistance by targeting MAPK2 signaling pathway","volume":"23","author":"Chen","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.biopha.2020.110231_bib0690","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.2147\/OTT.S159093","article-title":"miR-206 regulates 5-FU resistance by targeting Bcl-2 in colon cancer cells","volume":"11","author":"Meng","year":"2018","journal-title":"Onco. Ther."},{"issue":"17","key":"10.1016\/j.biopha.2020.110231_bib0695","doi-asserted-by":"crossref","first-page":"24510","DOI":"10.18632\/oncotarget.8229","article-title":"miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET","volume":"7","author":"Chen","year":"2016","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.biopha.2020.110231_bib0700","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.oraloncology.2010.12.001","article-title":"MicroRNA let-7a represses chemoresistance and tumourigenicity in head and neck cancer via stem-like properties ablation","volume":"47","author":"Yu","year":"2011","journal-title":"Oral Oncol."},{"issue":"2","key":"10.1016\/j.biopha.2020.110231_bib0705","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1159\/000481610","article-title":"CXCR4\/Let-7a axis regulates metastasis and chemoresistance of pancreatic cancer cells through targeting HMGA2","volume":"43","author":"Xiao","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"issue":"7","key":"10.1016\/j.biopha.2020.110231_bib0710","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133643","article-title":"Reduced let-7a is associated with chemoresistance in primary breast cancer","volume":"10","author":"Wu","year":"2015","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.biopha.2020.110231_bib0715","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/iub.2075","article-title":"LncRNA LOXL1-AS1\/miR-let-7a-5p\/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells","volume":"71","author":"Bai","year":"2019","journal-title":"IUBMB Life"},{"issue":"7","key":"10.1016\/j.biopha.2020.110231_bib0720","doi-asserted-by":"crossref","first-page":"941","DOI":"10.17219\/acem\/70745","article-title":"Differential altered expression of let-7a and miR-205 tumor-suppressor miRNAs in different subtypes of breast cancer under treatment with Taxol","volume":"27","author":"Asghari","year":"2018","journal-title":"Adv. Clin. Exp. Med."},{"key":"10.1016\/j.biopha.2020.110231_bib0725","doi-asserted-by":"crossref","first-page":"7253","DOI":"10.2147\/OTT.S116127","article-title":"Let-7a enhances the sensitivity of hepatocellular carcinoma cells to cetuximab by regulating STAT3 expression","volume":"9","author":"Xue","year":"2016","journal-title":"Onco. Ther."},{"issue":"3","key":"10.1016\/j.biopha.2020.110231_bib0730","doi-asserted-by":"crossref","first-page":"304","DOI":"10.2174\/1871520619666181213110258","article-title":"Let-7a could serve as a biomarker for chemo-responsiveness to docetaxel in gastric Cancer","volume":"19","author":"Shekari","year":"2019","journal-title":"Anticancer Agents Med. Chem."},{"issue":"23","key":"10.1016\/j.biopha.2020.110231_bib0735","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.2217\/fon-2016-0179","article-title":"miRNA-24-3p promotes cell proliferation and regulates chemosensitivity in head and neck squamous cell carcinoma by targeting CHD5","volume":"12","author":"Sun","year":"2016","journal-title":"Future Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110231_bib0740","doi-asserted-by":"crossref","first-page":"317","DOI":"10.18632\/oncotarget.2787","article-title":"Mir-24-3p downregulation contributes to VP16-DDP resistance in small-cell lung cancer by targeting ATG4A","volume":"6","author":"Pan","year":"2015","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.biopha.2020.110231_bib0745","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1039\/C7MB00362E","article-title":"A systems biology approach to identify microRNAs contributing to cisplatin resistance in human ovarian cancer cells","volume":"13","author":"Liu","year":"2017","journal-title":"Mol. Biosyst."},{"issue":"1","key":"10.1016\/j.biopha.2020.110231_bib0750","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13059-018-1604-0","article-title":"Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and neck cancer through targeting CDKN1B and ING5","volume":"20","author":"Qin","year":"2019","journal-title":"Genome Biol."},{"issue":"2","key":"10.1016\/j.biopha.2020.110231_bib0755","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1007\/s13277-015-4017-7","article-title":"Inhibition of microRNA-196a might reverse cisplatin resistance of A549\/DDP non-small-cell lung cancer cell line","volume":"37","author":"Li","year":"2016","journal-title":"Tumour Biol."},{"issue":"2","key":"10.1016\/j.biopha.2020.110231_bib0760","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.yexcr.2018.07.017","article-title":"HDAC inhibitor suppresses proliferation and tumorigenicity of drug-resistant chronic myeloid leukemia stem cells through regulation of hsa-miR-196a targeting BCR\/ABL1","volume":"370","author":"Bamodu","year":"2018","journal-title":"Exp. Cell Res."},{"issue":"9","key":"10.1016\/j.biopha.2020.110231_bib0765","doi-asserted-by":"crossref","first-page":"11623","DOI":"10.1007\/s13277-016-5125-8","article-title":"Role of long non-coding RNA in tumor drug resistance","volume":"37","author":"Deng","year":"2016","journal-title":"Tumour Biol."},{"issue":"5","key":"10.1016\/j.biopha.2020.110231_bib0770","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20180915","article-title":"Non-coding RNA in drug resistance of hepatocellular carcinoma","volume":"38","author":"Ding","year":"2018","journal-title":"Biosci. Rep."},{"issue":"14","key":"10.1016\/j.biopha.2020.110231_bib0775","doi-asserted-by":"crossref","first-page":"4876","DOI":"10.18632\/aging.102081","article-title":"LncRNA SLCO4A1-AS1 promotes colorectal cancer cell proliferation by enhancing autophagy via miR-508-3p\/PARD3 axis","volume":"11","author":"Wang","year":"2019","journal-title":"Aging (Albany NY)"},{"issue":"6","key":"10.1016\/j.biopha.2020.110231_bib0780","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1158\/1541-7786.MCR-05-0156","article-title":"Functional screen for genes responsible for tamoxifen resistance in human breast cancer cells","volume":"4","author":"Meijer","year":"2006","journal-title":"Mol. Cancer Res."},{"issue":"1","key":"10.1016\/j.biopha.2020.110231_bib0785","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0305-7372(79)80057-2","article-title":"Cisplatin (cis-diamminedichloroplatinum II)","volume":"6","author":"Prestayko","year":"1979","journal-title":"Cancer Treat. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2020.110231_bib0790","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10863-006-9059-5","article-title":"Mitochondria as a critical target of the chemotheraputic agent cisplatin in head and neck cancer","volume":"39","author":"Cullen","year":"2007","journal-title":"J. Bioenerg. Biomembr."},{"issue":"6","key":"10.1016\/j.biopha.2020.110231_bib0795","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.ymthe.2018.04.002","article-title":"Chemotherapy-induced long non-coding RNA 1 promotes metastasis and chemo-resistance of TSCC via the Wnt\/\u03b2-catenin signaling pathway","volume":"26","author":"Lin","year":"2018","journal-title":"Mol. Ther."},{"issue":"10","key":"10.1016\/j.biopha.2020.110231_bib0800","first-page":"598","article-title":"Knockdown of long noncoding RNA urothelial cancer-associated 1 enhances cisplatin chemosensitivity in tongue squamous cell carcinoma cells","volume":"71","author":"Wang","year":"2016","journal-title":"Pharmazie"},{"issue":"12","key":"10.1016\/j.biopha.2020.110231_bib0805","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1002\/cam4.1253","article-title":"LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression","volume":"6","author":"Fang","year":"2017","journal-title":"Cancer Med."},{"issue":"7","key":"10.1016\/j.biopha.2020.110231_bib0810","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1111\/febs.12737","article-title":"Long non-coding RNA UCA1 increases chemoresistance of bladder cancer cells by regulating Wnt signaling","volume":"281","author":"Fan","year":"2014","journal-title":"FEBS J."},{"issue":"3","key":"10.1016\/j.biopha.2020.110231_bib0815","doi-asserted-by":"crossref","first-page":"432","DOI":"10.4149\/neo_2015_051","article-title":"Involvement of SRPK1 in cisplatin resistance related to long non-coding RNA UCA1 in human ovarian cancer cells","volume":"62","author":"Wang","year":"2015","journal-title":"Neoplasma"},{"key":"10.1016\/j.biopha.2020.110231_bib0820","doi-asserted-by":"crossref","first-page":"23892","DOI":"10.1038\/srep23892","article-title":"LncRNA-UCA1 enhances cell proliferation and 5-fluorouracil resistance in colorectal cancer by inhibiting miR-204-5p","volume":"6","author":"Bian","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2020.110231_bib0825","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.12659\/MSM.900688","article-title":"Long non-coding RNA (LncRNA) urothelial carcinoma associated 1 (UCA1) increases multi-drug resistance of gastric cancer via downregulating miR-27b","volume":"22","author":"Fang","year":"2016","journal-title":"Med. Sci. Monit."},{"issue":"20","key":"10.1016\/j.biopha.2020.110231_bib0830","first-page":"4362","article-title":"Exosomes mediated transfer of lncRNA UCA1 results in increased tamoxifen resistance in breast cancer cells","volume":"20","author":"Xu","year":"2016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2020.110231_bib0835","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00280-016-3158-8","article-title":"The UCA1\/miR-204\/Sirt1 axis modulates docetaxel sensitivity of prostate cancer cells","volume":"78","author":"Wang","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"27","key":"10.1016\/j.biopha.2020.110231_bib0840","doi-asserted-by":"crossref","first-page":"23582","DOI":"10.18632\/oncotarget.4361","article-title":"Long non-coding RNA UCA1 induces non-T790M acquired resistance to EGFR-TKIs by activating the AKT\/mTOR pathway in EGFR-mutant non-small cell lung cancer","volume":"6","author":"Cheng","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.biopha.2020.110231_bib0845","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1089\/dna.2016.3533","article-title":"lncRNA UCA1 contributes to imatinib resistance by acting as a ceRNA against miR-16 in chronic myeloid leukemia cells","volume":"36","author":"Xiao","year":"2017","journal-title":"DNA Cell Biol."},{"issue":"7","key":"10.1016\/j.biopha.2020.110231_bib0850","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.cell.2007.06.014","article-title":"HOTAIR lifts noncoding RNAs to new levels","volume":"129","author":"Woo","year":"2007","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.biopha.2020.110231_bib0855","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/jop.12769","article-title":"RNA interference of long noncoding RNA HOTAIR suppresses autophagy and promotes apoptosis and sensitivity to cisplatin in oral squamous cell carcinoma","volume":"47","author":"Wang","year":"2018","journal-title":"J. Oral Pathol. Med."},{"issue":"1","key":"10.1016\/j.biopha.2020.110231_bib0860","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1080\/00016489.2016.1214982","article-title":"The role of long non-coding RNA HOTAIR in the progression and development of laryngeal squamous cell carcinoma interacting with EZH2","volume":"137","author":"Zheng","year":"2017","journal-title":"Acta Otolaryngol."},{"issue":"10","key":"10.1016\/j.biopha.2020.110231_bib0865","article-title":"The long noncoding RNA HOTAIR contributes to cisplatin resistance of human lung adenocarcinoma cells via downregualtion of p21(WAF1\/CIP1) expression","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.biopha.2020.110231_bib0870","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00280-016-2964-3","article-title":"Long noncoding RNA HOTAIR is a prognostic biomarker and inhibits chemosensitivity to doxorubicin in bladder transitional cell carcinoma","volume":"77","author":"Shang","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"21","key":"10.1016\/j.biopha.2020.110231_bib0875","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1038\/onc.2015.340","article-title":"LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer","volume":"35","author":"Xue","year":"2016","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.biopha.2020.110231_bib0880","doi-asserted-by":"crossref","first-page":"23111","DOI":"10.1002\/jcp.28874","article-title":"Long noncoding RNA LINC-PINT regulates laryngeal carcinoma cell stemness and chemoresistance through miR-425-5p\/PTCH1\/SHH axis","volume":"234","author":"Yuan","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"44","key":"10.1016\/j.biopha.2020.110231_bib0885","doi-asserted-by":"crossref","first-page":"71773","DOI":"10.18632\/oncotarget.12365","article-title":"Plasma and tumor levels of Linc-pint are diagnostic and prognostic biomarkers for pancreatic cancer","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.biopha.2020.110231_bib0890","doi-asserted-by":"crossref","first-page":"9594","DOI":"10.1002\/jcb.28236","article-title":"Long noncoding RNA LINC-PINT is inhibited in gastric cancer and predicts poor survival","volume":"120","author":"Feng","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"4","key":"10.1016\/j.biopha.2020.110231_bib0895","first-page":"258","article-title":"LncRNA LINC-PINT inhibits cancer cell proliferation, invasion, and migration in osteosarcoma by downregulating miRNA-21","volume":"34","author":"Liu","year":"2019","journal-title":"Cancer Biother. Radiopharm."},{"issue":"1","key":"10.1016\/j.biopha.2020.110231_bib0900","doi-asserted-by":"crossref","first-page":"4475","DOI":"10.1038\/s41467-018-06862-2","article-title":"A peptide encoded by circular form of LINC-PINT suppresses oncogenic transcriptional elongation in glioblastoma","volume":"9","author":"Zhang","year":"2018","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.biopha.2020.110231_bib0905","doi-asserted-by":"crossref","first-page":"R104","DOI":"10.1186\/gb-2013-14-9-r104","article-title":"Pint lincRNA connects the p53 pathway with epigenetic silencing by the Polycomb repressive complex 2","volume":"14","author":"Mar\u00edn-B\u00e9jar","year":"2013","journal-title":"Genome Biol."},{"issue":"9","key":"10.1016\/j.biopha.2020.110231_bib0910","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1111\/jcmm.13707","article-title":"Long non-coding RNA AFAP1-AS1\/miR-320a\/RBPJ axis regulates laryngeal carcinoma cell stemness and chemoresistance","volume":"22","author":"Yuan","year":"2018","journal-title":"J. Cell. Mol. Med."},{"issue":"5","key":"10.1016\/j.biopha.2020.110231_bib0915","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2013.01.019","article-title":"Hypomethylation of noncoding DNA regions and overexpression of the long noncoding RNA, AFAP1-AS1, in Barrett\u2019s esophagus and esophageal adenocarcinoma","volume":"144","author":"Wu","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2020.110231_bib0920","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12967-015-0490-4","article-title":"High expression of AFAP1-AS1 is associated with poor survival and short-term recurrence in pancreatic ductal adenocarcinoma","volume":"13","author":"Ye","year":"2015","journal-title":"J. Transl. Med."},{"issue":"4","key":"10.1016\/j.biopha.2020.110231_bib0925","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/JTO.0000000000000470","article-title":"Identification and validation of long noncoding RNA biomarkers in human non-small-cell lung carcinomas","volume":"10","author":"Yu","year":"2015","journal-title":"J. Thorac. Oncol."},{"issue":"4","key":"10.1016\/j.biopha.2020.110231_bib0930","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.3892\/ijo.2016.3385","article-title":"Long noncoding RNA AFAP1-AS1 indicates a poor prognosis of hepatocellular carcinoma and promotes cell proliferation and invasion via upregulation of the RhoA\/Rac2 signaling","volume":"48","author":"Zhang","year":"2016","journal-title":"Int. J. Oncol."},{"issue":"24","key":"10.1016\/j.biopha.2020.110231_bib0935","first-page":"5107","article-title":"Expression and functional role of long non-coding RNA AFAP1-AS1 in ovarian cancer","volume":"20","author":"Yang","year":"2016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.biopha.2020.110231_bib0940","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.biopha.2016.04.009","article-title":"Overexpression of lncRNA AFAP1-AS1 correlates with poor prognosis and promotes tumorigenesis in colorectal cancer","volume":"81","author":"Wang","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2020.110231_bib0945","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.biopha.2016.10.064","article-title":"Overexpression of LncRNA AFAP1-AS1 predicts poor prognosis and promotes cells proliferation and invasion in gallbladder cancer","volume":"84","author":"Ma","year":"2016","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.biopha.2020.110231_bib0950","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1159\/000477319","article-title":"Long noncoding RNA AFAP1-AS1 promoted tumor growth and invasion in Cholangiocarcinoma","volume":"42","author":"Lu","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"issue":"35","key":"10.1016\/j.biopha.2020.110231_bib0955","doi-asserted-by":"crossref","first-page":"58394","DOI":"10.18632\/oncotarget.16880","article-title":"LncRNA AFAP1-AS1 promotes growth and metastasis of cholangiocarcinoma cells","volume":"8","author":"Shi","year":"2017","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.biopha.2020.110231_bib0960","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1007\/s10620-017-4584-0","article-title":"Long noncoding RNA AFAP1-AS1 promotes cell proliferation and apoptosis of gastric cancer cells via PTEN\/p-AKT pathway","volume":"62","author":"Guo","year":"2017","journal-title":"Dig. Dis. Sci."},{"issue":"9","key":"10.1016\/j.biopha.2020.110231_bib0965","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1111\/cas.12989","article-title":"Long non-coding RNA ROR promotes proliferation, migration and chemoresistance of nasopharyngeal carcinoma","volume":"107","author":"Li","year":"2016","journal-title":"Cancer Sci."},{"issue":"2","key":"10.1016\/j.biopha.2020.110231_bib0970","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00280-016-3208-2","article-title":"Effects of long noncoding RNA-ROR on tamoxifen resistance of breast cancer cells by regulating microRNA-205","volume":"79","author":"Zhang","year":"2017","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2020.110231_bib0975","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s00280-016-3178-4","article-title":"Linc-ROR confers gemcitabine resistance to pancreatic cancer cells via inducing autophagy and modulating the miR-124\/PTBP1\/PKM2 axis","volume":"78","author":"Li","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2020.110231_bib0980","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317697568","article-title":"Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K\/Akt\/mTOR signaling pathway","volume":"39","author":"Shi","year":"2017","journal-title":"Tumour Biol."},{"issue":"20","key":"10.1016\/j.biopha.2020.110231_bib0985","doi-asserted-by":"crossref","first-page":"33144","DOI":"10.18632\/oncotarget.16562","article-title":"Long noncoding RNA ROR regulates chemoresistance in docetaxel-resistant lung adenocarcinoma cells via epithelial mesenchymal transition pathway","volume":"8","author":"Pan","year":"2017","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.biopha.2020.110231_bib0990","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1080\/15384047.2018.1450119","article-title":"LncRNA NEAT1\/let-7a-5p axis regulates the cisplatin resistance in nasopharyngeal carcinoma by targeting Rsf-1 and modulating the Ras-MAPK pathway","volume":"19","author":"Liu","year":"2018","journal-title":"Cancer Biol. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2020.110231_bib0995","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s12253-017-0233-3","article-title":"Silence of long noncoding RNA NEAT1 inhibits malignant biological behaviors and chemotherapy resistance in gastric Cancer","volume":"24","author":"Zhang","year":"2018","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.biopha.2020.110231_bib1000","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.2147\/CMAR.S171126","article-title":"Non-coding RNA NEAT1\/miR-214-3p contribute to doxorubicin resistance of urothelial bladder cancer preliminary through the Wnt\/\u03b2-catenin pathway","volume":"10","author":"Guo","year":"2018","journal-title":"Cancer Manag. Res."},{"issue":"28","key":"10.1016\/j.biopha.2020.110231_bib1005","doi-asserted-by":"crossref","first-page":"43337","DOI":"10.18632\/oncotarget.9712","article-title":"NEAT1 upregulates EGCG-induced CTR1 to enhance cisplatin sensitivity in lung cancer cells","volume":"7","author":"Jiang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2020.110231_bib1010","first-page":"1","article-title":"NEAT1 mediates paclitaxel-resistance of non-small cell of lung cancer through activation of Akt\/mTOR signalling pathway","author":"Li","year":"2019","journal-title":"J. Drug Target."},{"key":"10.1016\/j.biopha.2020.110231_bib1015","first-page":"1","article-title":"Long noncoding RNA NEAT1 suppresses sorafenib sensitivity of hepatocellular carcinoma cells via regulating miR-335-c-Met","author":"Chen","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"4","key":"10.1016\/j.biopha.2020.110231_bib1020","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41419-019-1513-5","article-title":"Long non-coding RNA NEAT1 confers oncogenic role in triple-negative breast cancer through modulating chemoresistance and cancer stemness","volume":"10","author":"Shin","year":"2019","journal-title":"Cell Death Dis."},{"issue":"7","key":"10.1016\/j.biopha.2020.110231_bib1025","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1080\/15384047.2018.1449610","article-title":"LncRNA PTCSC3 affects drug resistance of anaplastic thyroid cancer through STAT3\/INO80 pathway","volume":"19","author":"Wang","year":"2018","journal-title":"Cancer Biol. Ther."},{"issue":"8","key":"10.1016\/j.biopha.2020.110231_bib1030","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1080\/15384101.2017.1301334","article-title":"LncRNA CCAT1 modulates the sensitivity of paclitaxel in nasopharynx cancers cells via miR-181a\/CPEB2 axis","volume":"16","author":"Wang","year":"2017","journal-title":"Cell Cycle"},{"issue":"38","key":"10.1016\/j.biopha.2020.110231_bib1035","doi-asserted-by":"crossref","first-page":"62474","DOI":"10.18632\/oncotarget.11518","article-title":"Long noncoding RNA CCAT1 acts as an oncogene and promotes chemoresistance in docetaxel-resistant lung adenocarcinoma cells","volume":"7","author":"Chen","year":"2016","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.biopha.2020.110231_bib1040","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1080\/15384047.2017.1385679","article-title":"LncRNA CCAT1\/miR-130a-3p axis increases cisplatin resistance in non-small-cell lung cancer cell line by targeting SOX4","volume":"18","author":"Hu","year":"2017","journal-title":"Cancer Biol. Ther."},{"issue":"11","key":"10.1016\/j.biopha.2020.110231_bib1045","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1073\/pnas.73.11.3852","article-title":"Viroids are single-stranded covalently closed circular RNA molecules existing as highly base-paired rod-like structures","volume":"73","author":"Sanger","year":"1976","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.biopha.2020.110231_bib1050","article-title":"Circular RNA is expressed across the eukaryotic tree of life","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biopha.2020.110231_bib1055","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s13046-017-0624-z","article-title":"Circular RNAs: emerging cancer biomarkers and targets","volume":"36","author":"Zhang","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.biopha.2020.110231_bib1060","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13045-018-0643-z","article-title":"Function and clinical significance of circRNAs in solid tumors","volume":"11","author":"Geng","year":"2018","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110231_bib1065","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12943-019-1003-5","article-title":"Circular RNAs and their roles in head and neck cancers","volume":"18","author":"Guo","year":"2019","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.biopha.2020.110231_bib1070","first-page":"1752","article-title":"Circular RNA\u2011MTO1 suppresses breast cancer cell viability and reverses monastrol resistance through regulating the TRAF4\/Eg5 axis","volume":"53","author":"Liu","year":"2018","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110231_bib1075","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12943-017-0743-3","article-title":"Long noncoding RNA MALAT1 regulates autophagy associated chemoresistance via miR-23b-3p sequestration in gastric cancer","volume":"16","author":"YiRen","year":"2017","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.biopha.2020.110231_bib1080","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1080\/15548627.2017.1312041","article-title":"The emergence of noncoding RNAs as Heracles in autophagy","volume":"13","author":"Zhang","year":"2017","journal-title":"Autophagy"},{"issue":"9","key":"10.1016\/j.biopha.2020.110231_bib1085","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1002\/jcb.25967","article-title":"Regulatory role of N6 -methyladenosine (m6 a) methylation in RNA processing and human diseases","volume":"118","author":"Wei","year":"2017","journal-title":"J. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.biopha.2020.110231_bib1090","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41397-019-0110-4","article-title":"Dissecting the m6A methylation affection on afatinib resistance in non-small cell lung cancer","volume":"20","author":"Meng","year":"2020","journal-title":"Pharmacogenomics J."},{"issue":"5","key":"10.1016\/j.biopha.2020.110231_bib1095","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/mc.22782","article-title":"FTO regulates the chemo-radiotherapy resistance of cervical squamous cell carcinoma (CSCC) by targeting \u03b2-catenin through mRNA demethylation","volume":"57","author":"Zhou","year":"2018","journal-title":"Mol. Carcinog."},{"issue":"2","key":"10.1016\/j.biopha.2020.110231_bib1100","first-page":"621","article-title":"The epitranscriptome m6A writer METTL3 promotes chemo- and radioresistance in pancreatic cancer cells","volume":"52","author":"Taketo","year":"2018","journal-title":"Int. J. Oncol."},{"issue":"3","key":"10.1016\/j.biopha.2020.110231_bib1105","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.bbagrm.2018.12.002","article-title":"m6A modification of non-coding RNA and the control of mammalian gene expression","volume":"1862","author":"Coker","year":"2019","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"issue":"8","key":"10.1016\/j.biopha.2020.110231_bib1110","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1093\/nar\/gky130","article-title":"N6-Methyladenosine modification of lincRNA 1281 is critically required for mESC differentiation potential","volume":"46","author":"Yang","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.biopha.2020.110231_bib1115","doi-asserted-by":"crossref","first-page":"4695","DOI":"10.1038\/s41467-019-12651-2","article-title":"N6-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis","volume":"10","author":"Chen","year":"2019","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.biopha.2020.110231_bib1120","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1200\/JCO.2012.43.6097","article-title":"Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer","volume":"31","author":"Forastiere","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.biopha.2020.110231_bib1125","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nrd.2016.117","article-title":"Non-coding RNAs as drug targets","volume":"16","author":"Matsui","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"issue":"19","key":"10.1016\/j.biopha.2020.110231_bib1130","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.7150\/jca.34016","article-title":"Effect of HPV Infection on the Occurrence and Development of Laryngeal Cancer: A Review","volume":"10","author":"Yang","year":"2019","journal-title":"J. Cancer"},{"issue":"5","key":"10.1016\/j.biopha.2020.110231_bib1135","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1093\/annonc\/mdy102","article-title":"Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck: role, controversy, and future directions","volume":"29","author":"Haddad","year":"2018","journal-title":"Ann. Oncol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220304236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220304236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:00:29Z","timestamp":1760097629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332220304236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":227,"alternative-id":["S0753332220304236"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110231","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-coding RNAs in drug resistance of head and neck cancers: A review","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110231","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"110231"}}